ELITE PHARMS INC ELTP

$0.31 -13.53% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-13 View →
10-Q 10-Q 2026-08-13 View →
8-K 8-K 2026-08-10 View →
8-K 8-K 2026-08-04 View →
8-K 8-K 2026-06-29 View →
10-K 10-K 2026-06-29 View →
8-K 8-K 2026-06-23 View →
8-K 8-K 2026-06-15 View →
8-K 8-K 2026-06-01 View →
8-K 8-K 2026-04-02 View →
8-K 8-K 2026-02-17 View →
10-Q 10-Q 2026-02-17 View →
8-K 8-K 2026-02-11 View →
4 4 2026-01-13 View →
8-K 8-K 2025-11-14 View →
10-Q 10-Q 2025-11-14 View →
8-K 8-K 2025-11-12 View →
8-K 8-K 2025-11-10 View →
4 Insider transaction 2025-10-03 View →
4 4 2025-08-26 View →
8-K 8-K 2025-08-14 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-08-08 View →
4 PRIMARY DOCUMENT 2025-07-25 View →
4 Insider transaction 2025-07-10 View →
4 Insider transaction 2025-07-08 View →
8-K 8-K 2025-06-30 View →
10-K 10-K 2025-06-30 View →
8-K 8-K 2025-06-23 View →
8-K 8-K 2025-06-16 View →
8-K Current report (material event) 2025-04-30 View →
8-K Current report (material event) 2025-03-03 View →
8-K Current report (material event) 2025-02-13 View →
10-Q Quarterly report 2025-02-13 View →
8-K Current report (material event) 2024-12-26 View →
8-K Current report (material event) 2024-12-02 View →
8-K Current report (material event) 2024-11-18 View →
8-K Current report (material event) 2024-11-14 View →
10-Q Quarterly report 2024-11-14 View →
4 Insider transaction 2024-10-28 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.31
Market Cap
52-Week Range
$0.27 $0.74
Average Volume
653K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.